Advancing Global Innovation & Collaboration in Diabetes Care
Transforming diabetes prevention & care through strategic programs, research partnerships, and community-driven initiatives.
At OneGuild, we drive scalable, impactful solutions that integrate innovation, research, and community outreach. Our initiatives focus on advancing technology, improving education, and fostering collaboration to create sustainable change in diabetes care.
With over 550 million people living with diabetes worldwide—and projections rising to 800 million by 2045—the urgency for scalable solutions has never been greater. Our initiatives focus on improving access, advancing technology, and empowering communities, ensuring that the latest advancements reach those who need them most.
Advancing groundbreaking therapies and clinical innovations in diabetes care, limb preservation, and regenerative medicine through strategic collaborations, research, and education.
Canebosem Project
We are leading the Canebosem Project to research and develop cannabinoid-based medicines for the prevention and management of diabetes. We believe that cannabinoids can play an important role as a cost-effective tool in personalized care plans for patients...
The Program "Advancements in Negative Pressure Wound Therapy" is designed to provide professionals with a comprehensive update on the latest advancements in the field of negative pressure wound therapy (NPWT). Accredited presentations delve into ...
Innovations in Advanced Wound Care: Strategies for Optimizing Healing Outcomes
Master Class CME On Demand Learning
July 15, 2025 - July 15, 2026
The program "Innovations in Advanced Wound Care: Strategies for Optimizing Healing Outcomes" is designed to provide healthcare professionals with cutting-edge insights and evidence-based strategies in the field of wound care management. This comp...
Increasing Health Equity by Linking Diabetes Education to Health Providers in Underserved Communities
Diabetes is a complex chronic condition that requires ongoing management and care, and the burden of the disease is disproportionately borne by underserved populations, including low-income individuals, racial and ethnic minorities, and those living in rur...
Diabetes Prevention Program for Arab Women & Families
Arabs, mainly Muslim (82%), are the largest ethnic minority group in Israel, accounting for 20.7% of the total Israeli population. Most of the Arab population in Israel lives in predominantly Arab communities in close proximity to Jewish towns, with high e...
A collaboration between University at Buffalo (UB), Mount Sinai Beth Israel Hospital in NYC, and the Peter Sheehan Diabetes Care Foundation (OneGuild) aimed at a novel approach to collect and analyze de-identified patient data to address the Asian health d...
CareLabs is a research platform that accelerates the development of tools and solutions that eradicate the diabetes burden. CareLabs leverages CarePort to lead breakthrough collaborations with academia, health systems, and industries that improve diabetes ...
